Johnson & Johnson Investing Cash Flow
Johnson & Johnson (JNJ) reported Investing Cash Flow of -$2.15 billion for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-23
- Johnson & Johnson net cash provided by (used in) investing activities for the quarter ending 2026-06-28 was -$1.11B.
- Johnson & Johnson net cash provided by (used in) investing activities for the quarter ending 2026-03-29 was -$1.04B.
- Johnson & Johnson net cash provided by (used in) investing activities for the quarter ending 2025-12-28 was -$4.49B.
- Johnson & Johnson net cash provided by (used in) investing activities for the quarter ending 2025-09-28 was -$542.00M.
- Johnson & Johnson net cash provided by (used in) investing activities for fiscal 2025 was -$23.59B.
- Johnson & Johnson net cash provided by (used in) investing activities for fiscal 2024 was -$18.60B, a 2218.34% decline from fiscal 2023.
- Johnson & Johnson net cash provided by (used in) investing activities for fiscal 2023 was $878.00M.
- Johnson & Johnson net cash provided by (used in) investing activities for fiscal 2023 was -$12.37B.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-28 | -$1.11B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | -$2.15B 10-Q · filed 2026-07-23 | -$6.63B derived: sum of 3 quarters · filed 2026-07-23 | -$7.18B derived: sum of 4 quarters · filed 2026-07-23 | |
| 2026-03-29 | -$1.04B 10-Q · filed 2026-04-22 | -$5.53B derived: sum of 2 quarters · filed 2026-04-22 | -$6.07B derived: sum of 3 quarters · filed 2026-04-22 | -$24.33B derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-12-28 | -$4.49B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$5.03B derived: sum of 2 quarters · filed 2026-02-11 | -$23.29B derived: sum of 3 quarters · filed 2026-07-23 | -$23.59B 10-K · filed 2026-02-11 | |
| 2025-09-28 | -$542.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | -$18.81B derived: sum of 2 quarters · filed 2026-07-23 | -$19.10B 10-Q · filed 2025-10-22 | -$20.42B derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-06-29 | -$18.26B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | -$18.56B 10-Q · filed 2026-07-23 | -$19.88B derived: sum of 3 quarters · filed 2026-07-23 | -$23.01B derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-03-30 | -$297.00M 10-Q · filed 2026-04-22 | -$1.62B derived: sum of 2 quarters · filed 2026-04-22 | -$4.75B derived: sum of 3 quarters · filed 2026-04-22 | -$18.43B derived: sum of 4 quarters · filed 2026-04-22 | |
| 2024-12-29 | -$1.32B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$4.45B derived: sum of 2 quarters · filed 2026-02-11 | -$18.14B derived: sum of 3 quarters · filed 2026-02-11 | -$18.60B 10-K · filed 2026-02-11 | |
| 2024-09-29 | -$3.13B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | -$16.82B derived: sum of 2 quarters · filed 2025-10-22 | -$17.28B 10-Q · filed 2025-10-22 | -$18.48B derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-06-30 | -$13.69B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | -$14.15B 10-Q · filed 2025-07-24 | -$15.35B derived: sum of 3 quarters · filed 2026-02-11 | -$12.81B derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-03-31 | -$464.00M 10-Q · filed 2025-04-23 | -$1.67B derived: sum of 2 quarters · filed 2026-02-11 | $875.00M derived: sum of 3 quarters · filed 2026-02-11 | -$2.90B derived: sum of 4 quarters · filed 2026-02-11 | |
| 2023-12-31 | -$1.20B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.34B derived: sum of 2 quarters · filed 2026-02-11 | -$2.44B derived: sum of 3 quarters · filed 2026-02-11 | $878.00M 10-K · filed 2026-02-11 | |
| 2023-10-01 | $2.54B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-23 | -$1.24B derived: sum of 2 quarters · filed 2024-10-23 | $2.08B 10-Q · filed 2024-10-23 | -$2.32B derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-07-02 | -$3.78B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | -$461.00M 10-Q · filed 2024-07-25 | -$4.86B derived: sum of 3 quarters · filed 2025-02-13 | -$6.56B derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-04-02 | $3.31B 10-Q · filed 2024-05-01 | -$1.08B derived: sum of 2 quarters · filed 2025-02-13 | -$2.78B derived: sum of 3 quarters · filed 2025-02-13 | -$5.42B derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-01-01 | -$4.40B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$6.10B derived: sum of 2 quarters · filed 2025-02-13 | -$8.74B derived: sum of 3 quarters · filed 2025-02-13 | -$12.37B 10-K · filed 2025-02-13 | |
| 2022-10-02 | -$1.70B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | -$4.34B derived: sum of 2 quarters · filed 2023-10-27 | -$7.97B 10-Q · filed 2023-10-27 | -$13.33B derived: sum of 4 quarters · filed 2024-02-16 | |
| 2022-07-03 | -$2.64B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | -$6.27B 10-Q · filed 2023-07-31 | -$11.63B derived: sum of 3 quarters · filed 2024-02-16 | -$14.35B derived: sum of 4 quarters · filed 2024-02-16 | |
| 2022-04-03 | -$3.63B 10-Q · filed 2023-04-28 | -$8.99B derived: sum of 2 quarters · filed 2024-02-16 | -$11.71B derived: sum of 3 quarters · filed 2024-02-16 | -$12.13B derived: sum of 4 quarters · filed 2024-02-16 | |
| 2022-01-02 | -$5.36B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | -$8.08B derived: sum of 2 quarters · filed 2024-02-16 | -$8.50B derived: sum of 3 quarters · filed 2024-02-16 | -$8.68B 10-K · filed 2024-02-16 | |
| 2021-10-03 | -$2.72B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$3.14B derived: sum of 2 quarters · filed 2022-10-27 | -$3.32B 10-Q · filed 2022-10-27 | -$11.23B derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-07-04 | -$419.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | -$604.00M 10-Q · filed 2022-07-29 | -$8.51B derived: sum of 3 quarters · filed 2023-02-16 | -$13.33B derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-04-04 | -$185.00M 10-Q · filed 2022-04-29 | -$8.09B derived: sum of 2 quarters · filed 2023-02-16 | -$12.91B derived: sum of 3 quarters · filed 2023-02-16 | -$20.43B derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-01-03 | -$7.90B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$12.72B derived: sum of 2 quarters · filed 2023-02-16 | -$20.24B derived: sum of 3 quarters · filed 2023-02-16 | -$20.82B 10-K · filed 2023-02-16 | |
| 2020-09-27 | -$4.82B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$12.34B derived: sum of 2 quarters · filed 2021-10-29 | -$12.92B 10-Q · filed 2021-10-29 | -$14.27B derived: sum of 4 quarters · filed 2022-02-17 | |
| 2020-06-28 | -$7.52B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$8.10B 10-Q · filed 2021-07-29 | -$9.45B derived: sum of 3 quarters · filed 2022-02-17 | -$11.09B derived: sum of 4 quarters · filed 2022-02-17 | |
| 2020-03-29 | -$581.00M 10-Q · filed 2021-04-30 | -$1.93B derived: sum of 2 quarters · filed 2022-02-17 | -$3.57B derived: sum of 3 quarters · filed 2022-02-17 | -$5.36B derived: sum of 4 quarters · filed 2022-02-17 | |
| 2019-12-29 | -$1.34B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$2.99B derived: sum of 2 quarters · filed 2022-02-17 | -$4.78B derived: sum of 3 quarters · filed 2022-02-17 | -$6.19B 10-K · filed 2022-02-17 | |
| 2019-09-29 | -$1.65B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | -$3.43B derived: sum of 2 quarters · filed 2020-10-23 | -$4.85B 10-Q · filed 2020-10-23 | -$2.62B derived: sum of 4 quarters · filed 2021-02-22 | |
| 2019-06-30 | -$1.79B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | -$3.21B 10-Q · filed 2020-07-24 | -$977.00M derived: sum of 3 quarters · filed 2021-02-22 | -$5.25B derived: sum of 4 quarters · filed 2021-02-22 | |
| 2019-03-31 | -$1.42B 10-Q · filed 2020-04-29 | $811.00M derived: sum of 2 quarters · filed 2021-02-22 | -$3.46B derived: sum of 3 quarters · filed 2021-02-22 | -$3.66B derived: sum of 4 quarters · filed 2021-02-22 | |
| 2018-12-30 | $2.23B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | -$2.04B derived: sum of 2 quarters · filed 2021-02-22 | -$2.24B derived: sum of 3 quarters · filed 2021-02-22 | -$3.17B 10-K · filed 2021-02-22 | |
| 2018-09-30 | -$4.27B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | -$4.47B derived: sum of 2 quarters · filed 2019-10-28 | -$5.39B 10-Q · filed 2019-10-28 | -$5.90B derived: sum of 4 quarters · filed 2020-02-18 | |
| 2018-07-01 | -$201.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | -$1.13B 10-Q · filed 2019-07-29 | -$1.63B derived: sum of 3 quarters · filed 2020-02-18 | -$2.81B derived: sum of 4 quarters · filed 2020-02-18 | |
| 2018-04-01 | -$925.00M 10-Q · filed 2019-05-01 | -$1.43B derived: sum of 2 quarters · filed 2020-02-18 | -$2.61B derived: sum of 3 quarters · filed 2020-02-18 | -$14.86B derived: sum of 4 quarters · filed 2020-02-18 | |
| 2017-12-31 | -$505.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$1.69B derived: sum of 2 quarters · filed 2020-02-18 | -$13.93B derived: sum of 3 quarters · filed 2020-02-18 | -$14.87B 10-K · filed 2020-02-18 | |
| 2017-10-01 | -$1.18B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$13.43B derived: sum of 2 quarters · filed 2018-10-31 | -$14.36B 10-Q · filed 2018-10-31 | -$16.54B derived: sum of 4 quarters · filed 2019-02-20 | |
| 2017-07-02 | -$12.25B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$13.18B 10-Q · filed 2018-08-02 | -$15.36B derived: sum of 3 quarters · filed 2019-02-20 | -$17.73B derived: sum of 4 quarters · filed 2019-02-20 | |
| 2017-04-02 | -$936.00M 10-Q · filed 2018-05-01 | -$3.11B derived: sum of 2 quarters · filed 2019-02-20 | -$5.48B derived: sum of 3 quarters · filed 2019-02-20 | -$4.16B derived: sum of 4 quarters · filed 2019-02-20 | |
| 2017-01-01 | -$2.17B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$4.55B derived: sum of 2 quarters · filed 2019-02-20 | -$3.22B derived: sum of 3 quarters · filed 2019-02-20 | -$4.76B 10-K · filed 2019-02-20 | |
| 2016-10-02 | -$2.37B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$1.05B derived: sum of 2 quarters · filed 2017-11-02 | -$2.59B 10-Q · filed 2017-11-02 | -$3.98B derived: sum of 4 quarters · filed 2018-02-21 | |
| 2016-07-03 | $1.32B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$215.00M 10-Q · filed 2017-08-03 | -$1.61B derived: sum of 3 quarters · filed 2018-02-21 | -$2.61B derived: sum of 4 quarters · filed 2018-02-21 | |
| 2016-04-03 | -$1.54B 10-Q · filed 2017-05-08 | -$2.93B derived: sum of 2 quarters · filed 2018-02-21 | -$3.93B derived: sum of 3 quarters · filed 2018-02-21 | -$7.48B derived: sum of 4 quarters · filed 2018-02-21 | |
| 2016-01-03 | -$1.39B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$2.39B derived: sum of 2 quarters · filed 2018-02-21 | -$5.95B derived: sum of 3 quarters · filed 2018-02-21 | -$7.74B 10-K · filed 2018-02-21 | |
| 2015-09-27 | -$1.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$4.55B derived: sum of 2 quarters · filed 2016-11-04 | -$6.34B 10-Q · filed 2016-11-04 | -$9.27B derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-06-28 | -$3.55B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$5.34B 10-Q · filed 2016-08-04 | -$8.27B derived: sum of 3 quarters · filed 2017-02-27 | -$7.53B derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-03-29 | -$1.79B 10-Q · filed 2016-05-10 | -$4.71B derived: sum of 2 quarters · filed 2017-02-27 | -$3.98B derived: sum of 3 quarters · filed 2017-02-27 | -$12.07B derived: sum of 4 quarters · filed 2017-02-27 | |
| 2014-12-28 | -$2.92B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$2.19B derived: sum of 2 quarters · filed 2017-02-27 | -$10.28B derived: sum of 3 quarters · filed 2017-02-27 | -$12.30B 10-K · filed 2017-02-27 | |
| 2014-09-28 | $735.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | -$7.36B derived: sum of 2 quarters · filed 2015-10-30 | -$9.38B 10-Q · filed 2015-10-30 | -$10.96B derived: sum of 4 quarters · filed 2016-02-24 | |
| 2014-06-29 | -$8.09B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | -$10.12B 10-Q · filed 2015-07-31 | -$11.70B derived: sum of 3 quarters · filed 2016-02-24 | -$13.25B derived: sum of 4 quarters · filed 2016-02-24 | |
| 2014-03-30 | -$2.03B 10-Q · filed 2015-05-01 | -$3.60B derived: sum of 2 quarters · filed 2016-02-24 | -$5.16B derived: sum of 3 quarters · filed 2016-02-24 | -$5.73B derived: sum of 4 quarters · filed 2016-02-24 | |
| 2013-12-29 | -$1.58B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$3.13B derived: sum of 2 quarters · filed 2016-02-24 | -$3.70B derived: sum of 3 quarters · filed 2016-02-24 | -$5.10B 10-K · filed 2016-02-24 | |
| 2013-09-29 | -$1.55B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$2.12B derived: sum of 2 quarters · filed 2014-10-30 | -$3.52B 10-Q · filed 2014-10-30 | -$6.03B derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-06-30 | -$569.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$1.97B 10-Q · filed 2014-08-01 | -$4.47B derived: sum of 3 quarters · filed 2015-02-24 | -$6.41B derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-03-31 | -$1.40B 10-Q · filed 2014-05-02 | -$3.91B derived: sum of 2 quarters · filed 2015-02-24 | -$5.84B derived: sum of 3 quarters · filed 2015-02-24 | -$9.97B derived: sum of 4 quarters · filed 2015-02-24 | |
| 2012-12-30 | -$2.50B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$4.44B derived: sum of 2 quarters · filed 2015-02-24 | -$8.57B derived: sum of 3 quarters · filed 2015-02-24 | -$4.51B 10-K · filed 2015-02-24 | |
| 2012-09-30 | -$1.94B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | -$6.06B derived: sum of 2 quarters · filed 2013-11-04 | -$2.01B 10-Q · filed 2013-11-04 | $4.23B derived: sum of 4 quarters · filed 2014-02-21 | |
| 2012-07-01 | -$4.13B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$70.00M 10-Q · filed 2013-08-01 | -$13.40B 10-Q · filed 2012-08-02 | $6.17B derived: sum of 3 quarters · filed 2014-02-21 | $4.58B derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-04-01 | $4.06B 10-Q · filed 2013-05-03 | $10.29B derived: sum of 2 quarters · filed 2014-02-21 | $8.70B derived: sum of 3 quarters · filed 2014-02-21 | -$2.00B derived: sum of 4 quarters · filed 2014-02-21 | |
| 2012-01-01 | $6.24B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $4.65B derived: sum of 2 quarters · filed 2014-02-21 | -$6.05B derived: sum of 3 quarters · filed 2014-02-21 | -$4.61B 10-K · filed 2014-02-21 | |
| 2011-10-02 | -$1.59B derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$12.29B derived: sum of 2 quarters · filed 2012-11-09 | -$10.85B 10-Q · filed 2012-11-09 | -$12.25B derived: sum of 4 quarters · filed 2013-02-22 | |
| 2011-07-03 | -$10.70B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$9.26B 10-Q · filed 2012-08-02 | -$10.66B derived: sum of 3 quarters · filed 2013-02-22 | -$12.54B derived: sum of 4 quarters · filed 2013-02-22 | |
| 2011-04-03 | $1.44B 10-Q · filed 2012-05-07 | $36.00M derived: sum of 2 quarters · filed 2013-02-22 | -$1.84B derived: sum of 3 quarters · filed 2013-02-22 | -$4.53B derived: sum of 4 quarters · filed 2013-02-22 | |
| 2011-01-02 | -$1.40B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | -$3.28B derived: sum of 2 quarters · filed 2013-02-22 | -$5.97B derived: sum of 3 quarters · filed 2013-02-22 | -$7.85B 10-K · filed 2013-02-22 | |
| 2010-10-03 | -$1.88B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$4.57B derived: sum of 2 quarters · filed 2011-11-08 | -$6.45B 10-Q · filed 2011-11-08 | -$8.81B derived: sum of 4 quarters · filed 2012-02-23 | |
| 2010-07-04 | -$2.69B derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | -$4.58B 10-Q · filed 2011-08-09 | -$6.94B derived: sum of 3 quarters · filed 2012-02-23 | -$8.79B derived: sum of 4 quarters · filed 2012-02-23 | |
| 2010-04-04 | -$1.88B 10-Q · filed 2011-05-10 | -$4.25B derived: sum of 2 quarters · filed 2012-02-23 | -$6.10B derived: sum of 3 quarters · filed 2012-02-23 | -$8.40B derived: sum of 4 quarters · filed 2012-02-23 | |
| 2010-01-03 | -$2.36B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | -$4.22B derived: sum of 2 quarters · filed 2012-02-23 | -$6.52B derived: sum of 3 quarters · filed 2012-02-23 | -$7.60B 10-K · filed 2012-02-23 | |
| 2009-09-27 | -$1.85B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-10 | -$4.16B derived: sum of 2 quarters · filed 2010-11-10 | -$5.23B 10-Q · filed 2010-11-10 | -$7.75B derived: sum of 4 quarters · filed 2011-02-25 | |
| 2009-06-28 | -$2.30B derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-11 | -$3.38B 10-Q · filed 2010-08-11 | -$5.89B derived: sum of 3 quarters · filed 2011-02-25 | -$7.45B derived: sum of 4 quarters · filed 2011-02-25 | |
| 2009-03-29 | -$1.08B 10-Q · filed 2010-05-10 | -$3.59B derived: sum of 2 quarters · filed 2011-02-25 | -$5.15B derived: sum of 3 quarters · filed 2011-02-25 | ||
| 2008-12-28 | -$2.51B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | -$4.08B derived: sum of 2 quarters · filed 2011-02-25 | -$4.19B 10-K · filed 2011-02-25 | ||
| 2008-09-28 | -$1.56B derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-04 | -$1.67B 10-Q · filed 2009-11-04 | |||
| 2008-06-29 | -$112.00M 10-Q · filed 2009-08-04 | ||||
| 2007-12-30 | -$5.91B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |